Trending

immunooncology

MedImmune Expert Speaker Interview released in run up to Immuno-Oncology Conference

SMi Group reports: Exclusive interview with Grace Macaulay – MedImmune released in the run up to the Immuno-Oncology

X

MedImmune Expert Speaker Interview released in run up to Immuno-Oncology Conference

https://pharmaphorum.com/partner-content/medimmune-expert-speaker-interview-released-in-run-up-to-immuno-oncology-conference/

Immuno-Oncology

Immuno-Oncology

Immuno-Oncology Main Conference: 26 – 27 September 2018 Pre-Conference Workshops: 25 September 2018 Copthorne Tara Hotel, London, UK

X

Immuno-Oncology

https://pharmaphorum.com/events/immuno-oncology/

ASH 2017: CAR-T therapy and beyond

ASH 2017: CAR-T therapy and beyond

As the American Society of Hematology’s 2017 congress approaches, there’s plenty to be excited about – not just

X

ASH 2017: CAR-T therapy and beyond

https://pharmaphorum.com/views-analysis-oncology/ash-2017-car-t-therapy-beyond/

US tech firm takes aim at immuno-oncology outcomes

US tech firm takes aim at immuno-oncology outcomes

Company expands cancer patient monitoring platform to include checkpoint inhibitors.

X

US tech firm takes aim at immuno-oncology outcomes

https://pharmaphorum.com/news/witty-health-immuno-oncology-outcomes/

Boehringer and Sarah Cannon team for immune-oncology venture

Boehringer and Sarah Cannon team for immune-oncology venture

Partnership will seek to develop two immune checkpoint inhibitor candidates.

X

Boehringer and Sarah Cannon team for immune-oncology venture

https://pharmaphorum.com/news/boehringer-sarah-cannon-team-immune-oncology-venture/

CONTINUE TO SITE >

Close in 10 seconds

Pharmaphorum.com